Parenteral Drug Association - Comment

Document ID: FDA-2007-0614-0009
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 15 2008, at 10:37 AM Eastern Standard Time
Date Posted: February 19 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: December 4 2007, at 12:00 AM Eastern Standard Time
Comment Due Date: February 19 2008, at 11:59 PM Eastern Standard Time
Tracking Number: 803b0595
View Document:

This is comment on Proposed Rule

Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule

View Comment

Attached are the Parenteral Drug Association's (PDA) comments on FDA's proposed changes to tje GMP requirements as defined in 21 CFR Sections 210 and 11, Federal Dockets Management System Docket FDA-2007-0614 Robert L. Dana, Vice President, Quality Regulatory Affairs, PDA ... comments on FDA's proposed changes to the GMP requirements as defined in 21 CFR Sections 210 and 11,

Attachments:

Robert L. Dana - Comment

Title:
Robert L. Dana - Comment

Abstract:
Robert L. Dana, Vice President, Quality Regulatory Affairs, PDA ...is pleased to offer comments on the FDA’s proposed changes to the GMP requirements defined in 21 CFR § 210 and § 211

View Attachment:

Robert L. Dana - Comment

Title:
Robert L. Dana - Comment

Abstract:
Robert L. Dana, Vice President, Quality Regulatory Affairs, PDA ...Comments; Final Rule Changes to FDA 21 CFR 210 & 21 CFR 211

View Attachment:

Related Comments

Total: 2

Parenteral Drug Association - Comment
Public Submission Posted: 02/19/2008 ID: FDA-2007-0614-0009

Comment Period Closed
Feb 19,2008 11:59 PM ET

Compressed Gas Association (CGA) and the Gases and Welding Distributors Association (GAWDA) - Comment
Public Submission Posted: 08/08/2008 ID: FDA-2007-0614-0025

Comment Period Closed
Feb 19,2008 11:59 PM ET